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Goa and Diacylglycerol Kinase
Negatively Regulate
the Gqa Pathway in C. elegans
the egl-30 gene encodes a highly conserved homolog
of Gqa (82% identical to vertebrate forms) that is essen-
tial for life (Brundage et al., 1996). Hypomorphic egl-30
mutations result in strongly reduced rates of locomotion
and egg laying (Trent et al., 1983; Brundage et al., 1996).
Kenneth G. Miller, Melanie D. Emerson,
and James B. Rand*
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Our previous identification of egl-30 alleles in selec-
tions for aldicarb resistant mutants suggests that egl-
30 regulates synaptic transmission (Miller et al., 1996).
Summary Aldicarb, an inhibitor of acetylcholinesterase, is thought
to cause a toxic accumulation of secreted acetylcholine
We investigated the EGL-30 (Gqa) pathway in C. ele- (ACh) at synapses (Cambon et al., 1979; Risher et al.,
gans by using genetic screens to identify genes that 1987). Since the accumulation of secreted ACh can be
confer phenotypes similar to egl-30 mutants. One such reduced by mutations that decrease neurotransmitter
gene, egl-8, encodes a phospholipase Cb that is pres- release, aldicarb selection of mutants is a powerful tool
ent throughout the nervous system and near intestinal for investigating both the mechanics of synaptic trans-
cell junctions. EGL-30 and EGL-8 appear to positively mission and its regulation by signaling pathways. Of
regulate synaptic transmission because reducing their the 13 other aldicarb resistance genes that have been
function results in strong aldicarb resistance and slow cloned, all encode proteins that either function in the
locomotion rates. In contrast, GOA-1 (Goa) and DGK-1 synaptic vesicle cycle, are homologous to synaptic vesi-
(diacylglycerol kinase) appear to negatively regulate cle cycle proteins, or are localized to presynaptic re-
synaptic transmission, because reducing their func- gions (Miller et al., 1996; Iwasaki et al., 1997; Nonet et
tion results in strong aldicarb hypersensitivity and hy- al., 1997, 1998; Saifee et al., 1998; J. B. R. and K. Grun-
peractive locomotion. A genetic analysis suggests that dahl, data not shown). It seems unlikely that the EGL-
GOA-1 negatively regulates the EGL-30 pathway and 30 G protein directly functions in the synaptic vesicle
that DGK-1 antagonizes the EGL-30 pathway. cycle, but we hypothesize that it is involved in regulating
this machinery.
Introduction We observed that egl-30 (Gqa) mutants, along with
mutants in at least two other aldicarb resistance genes,
To better understand how synaptic transmission is regu- egl-10 and ric-8, have phenotypes that distinguish them
lated, we are investigating the signaling pathways that from other aldicarb resistant mutants. The finding that
regulate neurotransmitter secretion, the presynaptic egl-10 encodes a regulator of G protein signaling (Koelle
component of synaptic transmission. Biochemical stud- and Horvitz, 1996) suggests that aldicarb resistant mu-
ies have revealed that one common class of signaling tants in this subclass may encode signaling proteins that
pathways in neurons is built around heterotrimeric G regulate synaptic transmission. To identify additional
proteins of the Gq/G11 class (Watson and Arkinstall, genes in this subclass, we screened for aldicarb resis-
1994). The binding of neurotransmitter to a Gq-coupled tant mutants with phenotypes similar to egl-30 mutants.
receptor leads to activation of the G protein, which in The first part of this study describes one of these genes,
turn activates phospholipase Cb (PLCb) (Singer et al., egl-8, which we found encodes a homolog of PLCb, a
1997). PLCb cleaves phosphatidylinositol 4,5-bisphos- known downstream effector of Gqa.
phate (PIP2) into the small signaling molecules diacyl- To identify proteins that negatively regulate, or act
glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). antagonistically to, EGL-30 and EGL-8, we sought mu-
These molecules, or their analogs, lead to the stimula- tants with phenotypes that are opposite of egl-30 and
tion of neurotransmitter secretion (Malenka et al., 1986; egl-8 mutants. In so doing, we identified goa-1, which
Shapira et al., 1987; Berridge, 1998). One of the end- encodes a highly conserved homolog of Goa (Lochrie et
points of the Gq pathway in neurons, therefore, appears al., 1991; Mendel et al., 1995; Segalat et al., 1995), and
to be the presynaptic machinery that regulates neuro- dgk-1, also known as sag-1 (Hajdu-Cronin et al., 1999),
transmitter secretion. which encodes a diacylglycerol kinase (Nurrish et al.,
There are still major questions about the Gq pathway. 1999). GOA-1 and DGK-1 appear to negatively regulate
For example, are there other downstream effectors of
synaptic transmission because loss-of-function muta-
Gq besides PLCb? Is DAG an essential, or merely modu- tions in either gene result in hyperactive locomotion,
latory, effector of synaptic transmission? Does the Gq hyperactive egg laying, and, as we show in this study,
pathway interact with other G protein pathways, and, if
strong hypersensitivity to aldicarb (Mendel et al., 1995;so, how? Since synaptic transmission is a highly con-
Segalat et al., 1995; Hajdu-Cronin et al., 1999; Nurrishserved process, genetic studies in model systems pro-
et al., 1999). We used a genetic analysis to investigatevide a way to address these questions. In C. elegans,
the relationship of EGL-30 and EGL-8 to GOA-1 and
DGK-1. The results suggest that GOA-1 negatively regu-
lates the EGL-30 pathway and that DGK-1 acts antago-* To whom correspondence should be addressed (e-mail: randj@
omrf.ouhsc.edu). nistically to the EGL-30 pathway.
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Table 1. Locomotion Rates of egl-8 and egl-30 Mutants
Allele Locomotion Rate-
Body Bends/Minutea
N2 (wild-type) 15.6 6 1.7
egl-8 (md153) 15.9 6 1.3
egl-8 (md1933) 12 6 0.77
egl-8 (md2243) 6.7 6 0.42
egl-8 (n488) 4.3 6 0.56
egl-8 (md1971) 4.13 6 0.35
egl-8 (md1971)/sDf32 3.4 6 0.6b
egl-30 (ad805) 0.13 6 0.07
egl-30 (md186) 0.20 6 0.13
a Mean 6 standard error, N 5 10 young adults.
b Not significantly different from egl-8 (md1971) homozygotes (t-test,
p 5 0.24)
their locomotion rates on an agar surface. Wild-type
worms exhibit a stereotyped, spontaneous locomotion
behavior that is easily quantified by counting body
bends. Table 1 compares the mean locomotion rates of
wild-type worms and a representative group of egl-8
mutants that form an allelic series with respect to loco-
motion rate. The locomotion rates of the mildest alleles
are similar to wild-type, while those of the strongest are
reduced to about 25% of wild-type. The md1971 allele
must drastically reduce or eliminate the function of
Figure 1. egl-8 and egl-30 (Gqa) Mutants Share Similar Phenotypes EGL-8, since md1971 in trans to a deficiency had a
Photographs comparing wild-type C. elegans (N2) with strains con- locomotion rate not significantly different from md1971
taining mutations in snt-1 (a synaptotagmin homolog), egl-30, or homozygotes (Table 1). Molecular analysis of md1971
egl-8. Although all three mutants were isolated based on aldicarb (described below) supports this conclusion.
resistance, note the striking phenotypic differences between the
Although egl-8 and egl-30 mutants share similar phe-snt-1 mutant (smaller in size, few eggs in uterus, kinked or coiled
notypes, we observed that egl-30 reduction-of-functionposture) and egl-30 or egl-8 mutants (equal in size or larger than
mutants have substantially lower locomotion rates thanwild-type, bloated with eggs due to defective egg laying, decreased
body flexion). the egl-8 loss-of-function mutants (Table 1). Taken to-
gether with the previous finding that loss of EGL-30
function results in lethality (Brundage et al., 1996), this
suggests that EGL-30 has one or more additional func-Results
tions that are not shared with EGL-8.
Reduction-of-Function Mutations in egl-30 (Gqa)
and egl-8 Lead to Similar Phenotypes egl-8 Encodes a Phospholipase Cb Homolog
To investigate the molecular basis of the similaritiesMany aldicarb resistant mutants have phenotypes
roughly similar to snt-1 mutants (Figure 1). These mu- between egl-8 and egl-30 mutants, we cloned the egl-8
gene by transposon tagging (see Experimental Proce-tants frequently define genes that encode components
of the synaptic vesicle cycle (Miller et al., 1996). egl-30 dures). A sequence comparison identified EGL-8 as a
member of the phospholipase Cb (PLCb) family of pro-mutants can be distinguished from the snt-1-like class of
aldicarb resistant mutants by their larger size, reduced teins, most closely related to vertebrate PLCb4. Since
PLCb is a known downstream effector of Gqa, this resultbody flexion, and by the accumulation of eggs in their
uteri (Figure 1). To identify proteins that are important is consistent with our finding that EGL-30 and EGL-8
appear to act in the same pathway.for EGL-30 (Gqa) signaling, we screened for aldicarb
resistant mutants with phenotypes similar to egl-30 mu- Figure 2 shows a schematic comparison of EGL-8 and
PLCb4. The major domains of PLCb, all of which aretants. In so doing, we identified alleles of egl-30, egl-8,
egl-10, ric-8, and four genes that had not been pre- conserved in EGL-8, include an N-terminal pleckstrin
homology (PH) domain that mediates activation by Gbgviously identified. Here, we provide a genetic and molec-
ular characterization of egl-8, which has been previously for some PLCbs, and X and Y catalytic domains, wherein
resides the phospholipase activity (Singer et al., 1997).identified in genetic screens for defective egg laying
(Trent et al., 1983) and defecation (Thomas, 1990). The The most highly conserved regions are the X and Y
domains (68% and 75% identical, respectively), whichsimilar appearance of egl-30 and egl-8 mutants is shown
in Figure 1. are also identical in size between the two proteins. All
other regions of EGL-8 are larger than PLCb4, althoughThrough a series of aldicarb selections and subse-
quent noncomplementation screens, we identified 18 the ends of the two proteins can be precisely aligned.
Through sequence analysis of multiple cDNAs, weegl-8 alleles. As an initial assessment of the amount of
egl-8 function remaining in these alleles, we measured identified four exons that are alternatively spliced (Figure
Negative Regulation of the Gqa Pathway
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Figure 2. EGL-8 Encodes a PLCb Homolog
Schematic alignment of EGL-8 and rat PLCb4 (GenBank A48047)
amino acid sequences. The X and Y domains are shown as gray
Figure 3. The egl-8 Gene, Alternative Transcripts, and Mutations
shaded boxes. Patterned boxes indicate regions present in EGL-8
Schematic of egl-8 gene structure and mutations. Boxed regionsbut not rat PLCb4. Inverted V's delimit regions encoded by alterna-
are coding sequence, lines are noncoding. Positions at which intronstively spliced exons. The percentage of rat PLCb4 residues that are
interrupt the sequence are indicated by inverted arrowheads.identical to EGL-8 in various regions of the protein are indicated. A
Hatched boxes represent alternatively spliced exons, each of whichBLAST search of C. elegans genomic sequence (99% complete at
is labeled with the exon number. The major splice variants are asthe time of the search) identified five other genes related to EGL-8 (C.
follows: 8 of 9 cDNAs contained exon 4, and 9 of 11 cDNAs containedelegans predicted gene numbers: T01E8.3, F31B12.1, Y75B12B.g,
exon 10. Both cDNAs that were missing exon 10 were also missingR05G6.8, and K10F12.3). Four of these genes appear to be homologs
exon 9, which was present in only 4 out of 11 cDNAs. Exon 16 wasof phospholipases that are not part of the PLCb family. The fifth
present in 1 of 5 cDNAs. The positions and descriptions of fivegene (Y75B12B.g) appears distantly related to vertebrate PLCb2,
egl-8 mutations are indicated. The premature stop codon in md1971but it is considerably less related to PLCb2 than EGL-8.
results from a C to T change of nucleotide 3138 of the cDNA se-
quence (GenBank AF179426). The md153 lesion deletes cDNA nu-
cleotides 4411±4825. The lower diagram depicts the region that is
3, hatched regions). Due to the transcript size (z5 kb) deleted in n488, with only the relevant exons shown. The deletion
corresponds to nucleotides 23253±25630 on the genomic cosmidand the distant spacing of exons 4 and 16, we were
clone B0348.unable to obtain cDNAs that spanned all four regions
where we identified alternative splicing. However, the
are defective in egg laying, we expected to see stainingmajor splice variants contained exon 4 (8 of 9 cDNAs)
in the hermaphrodite-specific neurons (which controland exon 10 (9 of 11 cDNAs), while exons 9 and 16
egg laying) and/or the vulval muscles. However, promi-seemed to be more rarely included (Figure 3). Since
nent nonspecific staining around the vulva and weakmost of the sequences included in these exons cannot
EGL-8 staining in that region of the ventral cord pre-be aligned with PLCb4, the alternatively spliced se-
vented us from determining if EGL-8 is present at thosequences are not likely to be critical for PLC activity; they
locations. In the head ganglia, one pair of amphid neu-may, however, be important for regulating EGL-8 in a
rons showed especially strong staining. The amphidcell-, sex-, or stage-specific manner.
neurons relay sensory information, received via the am-
phid processes, to interneurons in the head gangliaegl-8 Mutations
(Bargmann, 1997). Within neurons, we observed EGL-8To investigate how egl-8 mutations affect the EGL-8
staining in both cell somas and in processes (Figureprotein, we analyzed genomic DNA from five egl-8 mu-
4B). The presence of EGL-8 in the nerve ring suggeststants. For reference, these are the same five mutants
that EGL-8 is present at synapses. Staining was notwhose locomotion rates are quantified in Table 1. The
detected in the sublateral processes or in the dorsalalleles that most strongly reduce EGL-8 function have
cord.lesions that disrupt the highly conserved Y domain. n488
EGL-8's intestinal staining was restricted to two lineshas a deletion that removes exons 10 and 11 and dis-
of staining running down the long axis of the body andrupts reading frame before the Y domain, md1933 has
to pairs of loop-like structures at regular intervals (Figurea Tc1 transposon insertion in the middle of the Y domain,
4A). The strongest staining was in the posterior region
and md2143 has a 2.1 kb insertion in an adjacent loca-
of the intestine. We used confocal microscopy to deter-
tion (Figure 3). Consistent with md1971 being a strong
mine that the two lines of staining are on the luminal
reduction- or loss-of-function allele, we found that this (apical) side of the intestinal cells. In double staining
mutant has an early stop codon that should prevent experiments, we observed that the lines of EGL-8 stain-
formation of part of the catalytic Y domain and the C-ter- ing colocalize with the staining of MH27, a monoclonal
minal region of the protein (Figure 3). antibody that stains epithelial and intestinal adherens
junctions (D. Hall, personal communication) (Figure 4C).
EGL-8 Protein Is Localized to the Nervous System MH27 staining also extended part of the way around
and Intestinal Cells each of the loops of EGL-8 staining, which may repre-
We produced a polyclonal antibody against the C-termi- sent sites where the ends of the intestinal cells join
nal region of EGL-8 and used it to visualize EGL-8 protein together (White, 1988). We conclude that, within intesti-
in wild-type and mutant strains. In wild-type worms, we nal cells, the majority of EGL-8 staining is restricted to
observed EGL-8 staining primarily in the nervous system regions near adherens junctions.
and the intestine (Figure 4A). The absence of this stain-
ing in egl-8 (md1971) (Figure 4D) and egl-8 (n488) (data EGL-30 (Gqa), EGL-8 (PLCb), and Diacylglycerol
not shown) demonstrates its specificity. Appear to Positively Regulate
We observed EGL-8 staining in most or all neurons, Synaptic Transmission
although the amount of staining varied between individ- Reducing the function of EGL-30 or EGL-8 results in
ual neurons. In general, neurons in the head and tail aldicarb resistance. We quantified the aldicarb sensitiv-
ganglia showed stronger staining than the motor neu- ity of egl-30 and egl-8 mutants by measuring their popu-
lation growth rates on various concentrations of aldicarbrons of the ventral cord (Figure 4A). Since egl-8 mutants
Neuron
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Figure 4. The EGL-8 Protein Is Localized to
the Nervous System and near Intestinal Cell
Junctions
(A) Indirect immunofluorescence staining of
EGL-8 protein in a wild-type C. elegans adult.
Note that the nervous system staining is
stronger in the head ganglia than in the ven-
tral cord. Confocal cross sections revealed
that the lines of staining running along the
body are near the luminal membrane of the
intestine, and the loop-like structures ema-
nate from the lumen of the intestine. At the
end of the intestine, EGL-8 staining becomes
brighter and the pattern more complex as the
intestinal cells connect to the epithelial rectal
cells and the anus is formed (White, 1988).
The vulval muscle staining is present in a mu-
tant control (see [D] in this figure).
(B) Enlarged view of EGL-8 staining in head
ganglia. Note staining of neuronal cell somas
as well as the axon processes of the nerve
ring.
(C) EGL-8 intestinal staining is localized near
cell junctions. Shown is a confocal image of
EGL-8 staining (green) and MH27 staining
(red) in the mid-body region of a wild-type L2
stage larvae. Regions of overlap show up as
yellow. The centrally located horizontal yel-
low and orange line is near the junctions
formed as pairs of intestinal cells wrap
around the lumen (junctions on the other side
of the lumen also stain but are not included
in this projection). Short vertical yellow and
red lines mark the anterior-posterior ends of
adjacent intestinal cells. Loops of EGL-8
staining (white arrowheads; see also [A] in
this figure) may correspond to the entire region of cell apposition, whereas MH27 only stains the septate junctions.
(D) The region of EGL-8 used for antibody production is not made in egl-8 (md1971), which serves as a control for specificity of the EGL-8
antibody. Nonspecific staining of the EGL-8 antibody can be seen in the pharynx, germ cells, vulval region, and cuticle. Double staining with
a monoclonal antibody to the neuronally localized CHA-1 protein (data not shown) was used as a control for permeabilization.
(Figure 5A). egl-30 and egl-8 mutants are able to grow tive locomotion and hypersensitivity to aldicarb, pheno-
on concentrations of aldicarb that are about 4-fold types that are opposite of egl-30 and egl-8 mutants.
higher than the concentration that stops the growth of Loss-of-function mutations in either goa-1 (Goa) or dgk-1
wild-type. Since aldicarb resistance is most commonly (diacylglycerol kinase) result in hyperactive locomotion
associated with mutations that decrease the rate of neu- and hyperactive egg laying (Mendel et al., 1995; Segalat
rotransmitter secretion, these results suggest that EGL- et al., 1995; Hajdu-Cronin et al., 1999; Nurrish et al.,
30 and EGL-8 normally function to positively regulate 1999). We observed that these mutants are also very
synaptic transmission. hypersensitive to aldicarb (Figure 5C). A loss-of-function
Diacylglycerol is a major end product of the Gqa-PLCb goa-1 allele is greater than 40-fold more hypersensitive
pathway in vertebrates. To address whether or not DAG than wild-type, while a loss-of-function dgk-1 allele is
can positively regulate synaptic transmission in C. ele- greater than 10-fold more hypersensitive than wild-type.
gans, we measured the aldicarb sensitivity of wild-type These data suggest that GOA-1 and DGK-1 normally
worms in the presence of phorbol esters, which are function to negatively regulate synaptic transmission.
molecular analogs of DAG. We observed that, in the
presence of 300 nM phorbol myristate acetate, wild-
GOA-1 Functions Upstream of EGL-30type worms are strikingly hypersensitive to aldicarb. The
or in a Parallel Intersecting Pathwayconcentration of aldicarb needed to stop the growth of
Given the opposite effects of EGL-30 and GOA-1 muta-phorbol ester-treated wild-type is about 35-fold lower
tions, these two G proteins appear to have oppositethan that needed to stop the growth of control-treated
roles in regulating synaptic transmission. What is thewild-type (Figure 5B). This suggests that DAG positively
relationship between EGL-30 and GOA-1? Does oneregulates synaptic transmission, consistent with previ-
negatively regulate the other, or do they act antagonisti-ous studies in vertebrates (Malenka et al., 1986; Shapira
cally? To investigate this question, we analyzed the phe-et al., 1987).
notypes of double mutant animals carrying strong re-
duction- or loss-of-function mutations in both genes.GOA-1 and DGK-1 Appear to Negatively Regulate
Our analysis of goa-1 egl-30 double mutants was com-Synaptic Transmission
plicated by the additive effects of the two mutations.To identify proteins that negatively regulate synaptic
transmission, we sought mutants that exhibit hyperac- goa-1 egl-30 double mutants exhibited very small brood
Negative Regulation of the Gqa Pathway
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Figure 6. GOA-1 Appears to Function Upstream of EGL-30 or in a
Parallel Intersecting Pathway
(A) The locomotion rates of the double mutants egl-30 (ad805); egl-
10 [nIs51] and egl-30 (ad805) goa-1 (n363) are indistinguishable from
egl-30 (ad805) single mutants. Shown are the mean locomotion
rates, expressed as body bends/minute of the double mutants and
control strains. Error bars represent the standard error of the mean
in a population of 10 young adult animals.
(B) The aldicarb resistance of egl-30 (ad805); egl-10 [nIs51] is similar
to egl-30 (ad805) single mutants. Shown are the aldicarb dose-
response curves for wild-type, egl-30 (ad805), egl-10 [nIs51], and
the double mutant egl-30 (ad805); egl-10 [nIs51]). Curves are repre-Figure 5. Phorbol Esters and Loss-of-Function Mutations in goa-1
sentative of duplicate experiments.and dgk-1 Cause Hypersensitivity to Aldicarb
Aldicarb sensitivity is quantified by measuring population growth
rates of wild-type and mutant strains on various concentrations of RGS protein that appears to negatively regulate GOA-1
aldicarb. 100% represents the number of progeny produced from (Koelle and Horvitz, 1996), a finding that is supported
a starting population of L1 larva over a 96 hr period in the absence by analogous studies in vertebrates (Berman et al., 1996;
of aldicarb. Curves are representative of duplicate experiments.
Hunt et al., 1996; Watson et al., 1996). egl-101 [nIs51](A) Reducing the function of egl-30 and egl-8 leads to aldicarb
animals exhibit hyperactive locomotion and hypersensi-resistance. (B) Phorbol esters cause hypersensitivity to aldicarb.
tivity to aldicarb, presumably because the excess EGL-Aldicarb dose-response curves of N2 (wild-type) in the presence
and absence of 300 nM phorbol myristate acetate. Note change in 10 protein inhibits GOA-1 activity. However, egl-101
scale compared to (A). (C) Loss-of-function mutations in goa-1 and [nIs51] animals do not exhibit the infertility and small
dgk-1 result in hypersensitivity to aldicarb. brood size phenotypes of goa-1 loss-of-function mu-
tants. We observed that egl-30 (ad805); egl-101 [nIs51]
double mutants are indistinguishable from egl-30 (ad805)
sizes, and about half of the eggs laid did not hatch (data single mutants with respect to locomotion rate (Fig-
not shown). As a result, we could not analyze these ure 6A). The aldicarb resistance of the double mutant
strains in our standard aldicarb sensitivity assay. We is also indistinguishable from the egl-30 (ad805) single
observed, however, that surviving goa-1 egl-30 double mutant at high aldicarb concentrations, although the
mutants are phenotypically similar to egl-30 single mu- double mutant appears slightly less resistant than egl-
tants. The mean locomotion rate of the double mutant is 30 (ad805) at low aldicarb concentrations (Figure 6B).
not significantly different from that of the egl-30 (ad805) Since the locomotion rate and aldicarb resistance phe-
single mutant (Figure 6A), and the double mutant also notypes of egl-30 (ad805) are not substantially affected
shared the reduced body flexion and egg-laying defec- by loss of goa-1 function or egl-10 overexpression, EGL-
tive phenotypes of the egl-30 single mutant (data not 10 and GOA-1 appear to act upstream of EGL-30 or in
shown). parallel intersecting pathway.
To further investigate the relationship of GOA-1 to
EGL-30, we analyzed the aldicarb sensitivity and loco- DGK-1 Acts Antagonistically to EGL-30
motion rate of egl-30 (ad805) in a double mutant combi- and EGL-8
nation with egl-101 [nIs51], an integrated transgenic What is the relationship of DGK-1 (diacylglycerol kinase)
to the EGL-30 pathway? Since DAG kinases reduce DAGarray that overexpresses wild-type EGL-10. EGL-10 is an
Neuron
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Figure 7. DGK-1 Appears to Act Antagonistically to EGL-30 and EGL-8
(A) The aldicarb resistance of egl-30 (ad805) is suppressed to near wild-type levels by a dgk-1 loss-of-function mutation. Shown are aldicarb
dose-response curves of egl-30; dgk-1 double mutants and control strains. Curves are representative of duplicate experiments. Similar results
were observed for egl-30 (md186); dgk-1 (sy428) and egl-30 (md186); dgk-1 (md1777) double mutants.
(B) The mean locomotion rates of egl-30; dgk-1 double mutants are in between those of egl-30 single mutants and wild-type. Error bars
represent the standard error of the mean in a population of 10 young adult animals.
(C and D) The aldicarb resistance and sluggish locomotion rate of egl-8 (md1971) is suppressed to near wild-type levels by a dgk-1 loss-of-
function mutation. Shown are aldicarb dose-response curves (C) and mean locomotion rates (D) of egl-8; dgk-1 double mutants and control
strains. Aldicarb sensitivity curves are representative of duplicate experiments, and locomotion rates are means 6 standard error of a population
of 10 animals. The mean locomotion of the egl-8; dgk-1 double mutant is not significantly different from wild-type (t-test, p 5 .149).
levels by converting DAG to phosphatidic acid (Sakane antagonistically to one another rather than in a linear
pathway.and Kanoh, 1997), we hypothesized that DGK-1 might
act antagonistically to the EGL-30 pathway, which DGK-1 also appears to act antagonistically to EGL-8.
Double mutants carrying loss-of-function mutations inshould produce DAG. To test this, we analyzed the phe-
notype of double mutants carrying a loss-of-function egl-8 and dgk-1 exhibited aldicarb sensitivities and loco-
motion rates that were close to wild-type (Figures 7Cmutation in dgk-1 plus a strong reduction-of-function
mutation in egl-30. The egl-30 mutation should result and 7D).
in low levels of DAG, while the dgk-1 mutants should
facilitate the accumulation of DAG. The double mutants
should tend to restore normal levels of DAG, resulting in Discussion
intermediate phenotypes that could be close to wild-type.
We found that egl-30; dgk-1 double mutants did in- egl-8 Encodes a Phospholipase Cb Homolog
that Is Localized to the Nervous Systemdeed exhibit intermediate aldicarb sensitivities that were
close to wild-type (Figure 7A). The mean locomotion and near Intestinal Cell Junctions
To investigate the EGL-30 pathway in C. elegans, werates of these strains were also intermediate, falling in
between that of egl-30 single mutants and wild-type screened for aldicarb resistant mutants with phenotypes
similar to egl-30. In so doing, we identified, among other(Figure 7B). The relationship of DGK-1 to EGL-30, there-
fore, appears to be distinctly different from the relation- genes, alleles of egl-8. egl-30 and egl-8 are thus part of
a group of at least 30 genes in C. elegans that can confership of GOA-1 to EGL-30. Strong reduction-of-function
egl-30 mutants are not suppressed by goa-1 (loss of resistance to inhibitors of cholinesterase (also known
as Ric genes) (Miller et al., 1996; K. G. M. and J. B. R.,function) or egl-10 (overexpression), but they are sup-
pressed by loss-of-function mutations in dgk-1. Since unpublished data). The aldicarb resistance of egl-30 and
egl-8 mutants suggests that they have reduced rates ofthe egl-30; dgk-1 double mutants exhibited phenotypes
that were in between that of either single mutant, these neurotransmitter secretion. Further studies using elec-
trophysiology, however, will be needed to test this.data are most consistent with EGL-30 and DGK-1 acting
Negative Regulation of the Gqa Pathway
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Our molecular analysis of the egl-8 gene demon- What are the downstream targets of DAG? Protein
kinase C (PKC), which is directly activated by DAG andstrates that it encodes a PLCb homolog that is most
closely related to vertebrate PLCb4. Using immuno- calcium (Berridge, 1984), could potentially regulate syn-
aptic transmission by phosphorylating synaptic vesiclestaining, we found that the EGL-8 protein is localized
to neuronal somas and processes and near intestinal cycle proteins. Studies have shown that interactions
between SNAP-25 and syntaxin, between Munc-18 andcell junctions. Within the nervous system, we observed
EGL-8 staining in most neurons, although the amount syntaxin, and between N-type calcium channels and
syntaxin or SNAP-25 are all inhibited by phosphorylationof staining varied in different regions. The relatively
stronger staining in the head ganglia compared to the with PKC (Fujita et al., 1996; Shimazaki et al., 1996;
Yokoyama et al., 1997). Although these studies are con-ventral cord may indicate that EGL-8 plays a more im-
portant role in interneurons and sensory neurons than sistent with a role for PKC in regulating synaptic vesicle
fusion, their in vivo relevance is not yet clear, and therein the motor neurons that comprise most of the ventral
cord. Alternatively, motor neurons might require less are many other potential PKC targets in the synapse.
Another likely downstream target of DAG in the syn-EGL-8 to achieve the same level of function. The aldicarb
resistance of EGL-8 suggests a defect in the synaptic apse is UNC-13, which, like PKC, contains a C1 domain
that binds phorbol esters and diacylglycerol (Maruyamatransmission of acetylcholine; however, EGL-8 is also
present in noncholinergic neurons (K. M. and J. Duerr, and Brenner, 1991). Consistent with a role in regulating
neurotransmitter secretion, UNC-13 and its vertebrateunpublished data), which suggests that it is involved in
their function as well. homolog are localized to presynapses (Betz et al., 1998;
R. Eustance and J. B. R., unpublished data). unc-13The presence of EGL-8 in the adult nervous system
suggests that it functions in mature neurons. Although reduction-of-function mutants are also strongly aldicarb
resistant and exhibit severely reduced locomotion ratesa subtle developmental role cannot be ruled out, a study
using the conditional allele egl-8 (sa32) concluded that (Nguyen et al., 1995; Miller et al., 1996). A vertebrate
homolog of UNC-13 interacts with syntaxin (Betz et al.,egl-8 is not required for proper development of the egg
laying, defecation, or locomotion behaviors (Thomas, 1997), an essential component of the synaptic vesicle
fusion machinery (Schulze et al., 1995). UNC-13, there-1990).
EGL-8's intestinal localization could be related to its fore, could be a crucial link between the EGL-30 (Gqa)
pathway and neurotransmitter secretion.role in the posterior body wall muscle contraction (pboc)
step of the defecation cycle. The observation that se-
vere synaptic mutants exhibit outwardly normal pbocs GOA-1 and DGK-1 Negatively Regulate
(K. G. M., unpublished data) suggests that the signals the EGL-30 (Gqa) Pathway
that generate the pboc originate from a nonneuronal The hyperactive locomotion and hypersensitivity to aldi-
source. Consistent with the intestine being a source of carb exhibited by loss-of-function mutants in goa-1 and
the pboc signal is the recent finding that the flr-1 gene, dgk-1 suggest that GOA-1 and DGK-1 negatively regu-
which plays a role in the pboc and defecation cycle late synaptic transmission. Our genetic analysis sug-
rhythm, is expressed in intestinal cells (Take-uchi et al., gests that both proteins interact with the EGL-30 path-
1998). Further investigation using genetic mosaics will way, although they appear to do so in distinctly different
be required to determine if EGL-8 functions in the intes- ways. Our analysis of egl-30; dgk-1 doubles and egl-8;
tine to regulate the pboc. EGL-30 seems not to play a dgk-1 doubles suggests that EGL-30 and EGL-8 act
role in the pboc, since strong reduction-of-function egl- antagonistically to DGK-1. The knowledge that dgk-1
30 mutants exhibit apparently normal pbocs (K. G. M., encodes a diacylglycerol kinase (Nurrish et al., 1999)
unpublished data). suggests a simple explanation for these results. Specifi-
cally, we suggest that low DAG levels in the neurons of
egl-30 and egl-8 mutants are restored to near normalThe EGL-30 (Gqa) Pathway
The phenotypes that result from reducing the function levels by loss-of-function mutations in dgk-1, which
should block phosphorylation of DAG (i.e., block its con-of EGL-30 and EGL-8 suggest that they function in a
common pathway to positively regulate synaptic trans- version to phosphatidic acid). Although the source of
this putative DAG in the egl-30 and egl-8 mutants hasmission. Since vertebrate studies have shown that Gqa
activates PLCb (Singer et al., 1997), we think it is likely not been determined, it could be derived from partial
function of egl-30 pathway or from one of the otherthat EGL-30 activates EGL-8. EGL-8, however, appears
not to mediate all of the effects of EGL-30, because pathways that are known to produce DAG (Singer et al.,
1997).our comparison of egl-30 and egl-8 mutant phenotypes
suggests that substantial EGL-30 signaling occurs inde- Our analysis of goa-1 egl-30 double mutants and egl-
101 [nIs51]; egl-30 double mutants suggests that GOA-1pendently of EGL-8. One or more of the other genes
that we identified in our screens may encode additional acts upstream of the EGL-30 pathway. However, this
kind of genetic analysis cannot determine which compo-EGL-30 effectors.
Since activation of PLCb by Gqa leads to the cleavage nent(s) of the EGL-30 pathway are regulated by GOA-1.
GOA-1 could act upstream of the EGL-30 G protein itselfof PIP2 to form DAG and IP3 (Berridge, 1984), a deficiency
of DAG and/or IP3 in egl-30 and egl-8 mutants may cause or, alternatively, it could regulate a downstream effector
or product of the EGL-30 pathway. For example, GOA-1or contribute to their shared phenotypes. Although we
have not yet determined if IP3 plays a role in synaptic could act to prevent the accumulation of DAG, possibly
by activating DGK-1. If this were the case, however,transmission in C. elegans, our finding that phorbol es-
ters induce strong hypersensitivity to aldicarb suggests goa-1 mutants, like dgk-1 mutants, should suppress egl-
30 mutants, and they do not. We think, therefore, thatthat DAG can positively regulate synaptic transmission.
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I; dgk-1 (sy428) X, RM2183 egl-30 (md186) I; dgk-1 (md1777) X,GOA-1 most likely regulates upstream components of
RM2210 egl-30 (md186) I; dgk-1 (sy428) X, RM2226 goa-1 (n363) I,the EGL-30 pathway, such as EGL-30 itself.
RM2279 goa-1 (n363) egl-30 (ad805) I, RM2278 goa-1 (n363) egl-30GOA-1 could negatively regulate the EGL-30 pathway
(md186) I, TR638 mut-3 (r456).
directly or through intermediate proteins. One candidate
for an intermediate protein is EAT-16, an RGS protein
Genetic Screensthat appears to negatively regulate EGL-30 and also
Four different mutant screens were used to identify the egl-8 mu-appears to function downstream of GOA-1 (Hajdu-Cro-
tants described here. In the first, RM25 or the Tc1 mutator strainnin et al., 1999). Consistent with a role in negatively
TR638 was used as a starting strain to isolate spontaneous aldicarb
regulating EGL-30, reducing the function of EAT-16 re- resistant mutants as previously described (Miller et al., 1996). The
sults in hyperactive locomotion, hyperactive egg laying, egl-8 alleles identified in this screen were md153 (described here)
and seven other alleles (six derived from RM25, one derived fromand hypersensitivity to aldicarb (Hajdu-Cronin et al.,
TR638). In the second screen, TR638 was again used as the starting1999; K. G. M., unpublished data).
strain to look for Tc1-induced aldicarb resistant mutants, but aGene expression and protein localization data support
secondary screen was applied to identify mutants with phenotypesan important assumption of this model, which is that
similar to egl-30 and/or egl-10 mutants (defective egg laying and/
these proteins function together in the same cells. EGL- or straightened posture). Four hundred independent lines were ana-
30, GOA-1, DGK-1, EGL-10, EAT-16, and EGL-8 appear lyzed in this screen (z20,000 animals per line), and a single egl-8
allele, md1933, was identified. In a similar screen, 8000 EMS-muta-to be broadly, though not in all cases exclusively, ex-
genized genomes were subjected to aldicarb selection followedpressed in the nervous system (Mendel et al., 1995;
again by secondary screening for phenotypes similar to egl-10 and/Segalat et al., 1995; Koelle and Horvitz, 1996; Hajdu-
or egl-30. This screen identified five alleles of egl-8 includingCronin et al., 1999; Lackner et al., 1999 [this issue of
md1971 (described here). The fourth screen was a noncomplemen-
Neuron]; Nurrish et al., 1999; this paper). These studies tation screen in which EMS mutagenized N2 males were crossed
suggest that the GOA-1/EGL-30 signaling network is a to egl-8 (md1933) dpy-11 (e224). Plates were allowed to produce
F1 cross progeny for 2 days, at which point progeny were rinsedcore component of most, or all, neurons in C. elegans.
off and transferred to 0.3 mM aldicarb plates for selection of non-
complementing cross progeny (the dpy-11 mutation causes self-
Why Negatively Regulate the EGL-30 (Gqa) Pathway? progeny to die under these conditions). Five alleles of egl-8 were
In vertebrates, many neurotransmitters/neuropeptides identified in this way, including md2243 (described here).
have been shown to activate Gqa via G protein linked Mutants identified in these screens (with the exception of the
noncomplementation screen) were mapped to a chromosomal sub-receptors (Watson and Arkinstall, 1994). These include
region using STS mapping of EM1002 strain polymorphisms (Wil-acetylcholine, glutamate, and serotonin, all of which are
liams et al., 1992). Mutants were identified as egl-8 alleles after firstpresent in C. elegans (Rand and Nonet, 1997). Since the
mapping them to the left arm of linkage group (LG) V (left of STS
proteins of the GOA-1/EGL-30 signaling network appear marker stP3) followed by complementation testing. Several combi-
to be widely expressed in the nervous system, EGL-30 nations of egl-8 alleles (n488/md2116, n488/md1971, and md2116/
activation may be coupled to different neurotransmitters md1971) showed partial complementation for the Egl phenotype
but noncomplementation for the aldicarb resistance and locomotionin a cell-specific manner.
phenotypes.If the activity of the Gqa pathway can be controlled
dgk-1 (md1777) was obtained in a screen for suppressors of thevia its input (i.e., neurotransmitters binding to receptors),
mutant ric-8 (md303) and was mapped left of stP41 on the left
why is there a mechanism for its negative regulation? arm of LG X by STS mapping. Subsequent complementation tests
One possibility is that it gives synapses the added flexi- revealed that its hyperactive locomotion and egg laying are allelic
bility of a gain control mechanism. Depending on the with dgk-1 (nu199) and sag-1 (sy428).
Mutants identified in this study or obtained from other labs wereactivity of the negative regulators, the output of the
backcrossed at least twice before use in assays or double mutantsynapse (i.e., the amount of neurotransmitter released)
construction.could vary in response to the same amount of input.
Interestingly, GOA-1 and DGK-1 provide two different
mechanisms for negative regulation that could be used Double Mutant Strain Construction and Verification
For double mutant constructions, we chose strong reduction-of-in concert. Activation of GOA-1 should decrease DAG
function or loss-of-function alleles. egl-30 (ad805) and egl-30production, while concurrent activation of DGK-1 should
(md186) are strong reduction-of-function alleles (Brundage et al.,deplete the existing stores of DAG, an effect that would
1996; Miller et al., 1996; this paper), while egl-8 (md1971), dgk-1
shorten the time needed to downregulate the pathway. (sy428), and goa-1 (n363) are loss-of-function or null alleles (this
paper; Segalat et al., 1995; Hajdu-Cronin et al., 1999). dgk-1 (sy428)
contains an early stop codon in the coding sequences of dgk-1Experimental Procedures
(S. Nurrish and J. Kaplan, personal communication). The molecular
lesion of dgk-1 (md1777) has not been determined, but comparisonStrains
Worms were cultured using standard methods (Brenner, 1974). Wild- to dgk-1 (sy428) suggests that it strongly reduces dgk-1 function.
Double mutants were constructed using standard genetic meth-type worms were C. elegans variety Bristol, strain N2. Variety Berg-
erac, strain EM1002, was used for STS mapping. TR638 and RM25, ods, without additional marker mutations. Homozygosity of alleles
in each double mutant was confirmed by sequencing amplified ge-derived from TR403, were used as starting strains for isolating spon-
taneous aldicarb resistant mutants. The following C. elegans mutant nomic DNA of strains containing egl-30 (ad805), egl-30 (md186), or
egl-8 (md1971), and by PCR for strains containing goa-1 (n363).strains were used in this work: RM2224 dgk-1 (sy428) X, RM1790
dgk-1 (md1777) X, KP828 dgk-1 (nu199) X, MT1083 egl-8 (n488) V, Homozygosity of dgk-1 alleles (X-linked) was confirmed by noncom-
plementation tests. Homozygosity of egl-101 [nIs51] in double mu-RM153 egl-8 (md153) V, RM2163 egl-8 (md1933) V, RM2215 egl-8
(md1933 md1934R) V, RM2243 egl-8 (md2243) V, RM2221 egl-8 tants was confirmed by PCR, using primers specific for the ampicillin
resistance gene of the integrated array (25/25 progeny of the cloned(md1971) V, RM2246 egl-8 (md1971) V; dgk-1 (sy428) X, RM2158
egl-8 (md1933) V; dpy-11 (e224) V, MT8190 lin-15 (n765) egl-101 double mutant contained this marker), and by outcrossing to wild-
type, where we observed segregation of the egl-10 overexpressing[nIs51], RM2289 egl-30 (ad805); lin-15 (n765) egl-101 [nIs51], DA823
egl-30 (ad805) I, RM1758 egl-30 (md186) I, RM2217 egl-30 (ad805) phenotype in 100% of the F1 generation.
Negative Regulation of the Gqa Pathway
331
Cloning and Analysis of egl-8 Genomic and cDNA Sequences and EGL-8 fusion protein was purified under denaturing conditions
using nickel resin.Genomic sequence corresponding to egl-8 was identified using a
transposon display method developed by Henri van Luenen and Rabbits were injected with 500 mg of fusion protein and boosted
four times. To affinity purify EGL-8 antibodies, 1.0 mg of EGL-8Ronald Plasterk. In brief, the egl-8 (md1933) mutant was obtained
from the Tc1 mutator strain TR638 as described above. A wild- fusion protein was run out on a 9% SDS-PAGE gel and blotted to
nitrocellulose. The blot was stained with Ponceau S, and the EGL-8type revertant of the mutant was subsequently isolated (md1933
md1934R), and Tc1 copy number of the mutant and revertant was fusion protein band was excised and washed for 30 min in blocker
(10 mM tris [pH 8.0], 0.05% Tween 20, 150 mM NaCl, 3% nonfatreduced by backcrossing. Genomic DNA prepared from these
strains and a wild-type control was digested with the 4-cutter Sau dry milk, and 0.05% sodium azide) with rocking. The blocker solution
was then removed, and 4.5 ml of serum was incubated with the3A followed by heat inactivation. A vectorette oligo cassette (con-
sisting of 55 nucleotide complementary oligos that form a Sau 3A EGL-8 protein on the nitrocellulose strips for 1 hr. The serum was
removed, and the strips were rinsed with TBST (10 mM tris [pH 8.0],overhang upon annealing) was ligated to the digested genomic DNA.
Primers complementary to Tc1 and the vectorette cassette were 0.05% Tween 20, and 150 mM NaCl), followed by 3 3 5 min washes
in TBST. Antibodies were eluted from the strips using glycine elutionthen used to amplify genomic sequences flanking all of the Tc1s in
the genome. After 20 cycles, the PCR reaction was diluted 100-fold, buffer (5 mM glycine, 0.01% BSA, 0.05% Tween 20, and 500 mM
NaCl [pH 2.3]) followed by 50 mM triethylamine (pH 11.5). Secondaryand a second PCR reaction was performed using nested primers.
The nested Tc1 primer was end-labeled with 33P gATP before inclu- antibodies were adsorbed against 4% formaldehyde-fixed worms
to remove antibodies to nematode proteins.sion in the reaction. After 20 cycles, a portion of the reaction was
run out on a 6% sequencing gel. The gel was dried and exposed to Whole mounts of C. elegans for antibody staining were prepared
as previously described, using the methanol/acetone fixation proto-X-ray film, producing a pattern of bands made up of Tc1-containing
genomic Sau 3A fragments. The Tc1 pattern was compared between col (Duerr et al., 1999). Affinity-purified anti-EGL-8 antibodies
(KM3B-5.1) were used at a 1/500 dilution. In double staining experi-wild-type, mutant, and revertant strains, and a single band was
identified that was present in the md1933 mutant but was missing ments, the mouse monoclonal antibodies MH27 (1/1000 dilution)
or anti-CHA-1 (undiluted supernatant) were included. Secondaryin wild-type and the revertant. The dried gel was aligned with the
autoradiogram, and the band was excised, eluted in water, and antibodies were donkey anti-rabbit antibodies (Jackson ImmunoRe-
search) coupled to Alexa 488 dye (Molecular Probes). In doubleamplified for 30 cycles using the same primers as for the second
PCR of the transposon display. The amplification product was se- staining experiments, donkey anti-mouse antibodies coupled to Cy3
were also added. Slides were viewed and images were collectedquenced, labeled, and used to screen a C. elegans mixed-stage
oligo dT-primed cDNA library, which resulted in the isolation of using a Leica TCS NT Confocal Microscope and accompanying
software.cDNAs derived from the 39 two thirds of the egl-8 transcript. Geno-
mic sequence was analyzed with Genefinder to predict the 59 most
exon of the gene, and primers designed from this exon were used Aldicarb Sensitivity Assays
Aldicarb sensitivity was quantified by placing a fixed number of L1to amplify a 100 bp fragment from genomic DNA, which was used
to probe a C. elegans mixed-stage random-primed cDNA library. A stage larva on culture plates containing 0, 10, 25, 50, 100, 200, 400,
800, or 1600 mM aldicarb and allowing them to grow at 208C for 965002 nucleotide chimeric sequence was assembled from all of the
unique sequence in the 59 and 39 cDNA clones. In several cDNA hr. Growth was then stopped by putting the plates at 48C. The
number of progeny (eggs and larva) produced during this periodclones, this sequence was preceded by a portion of the trans-
spliced leader SL1, which is found on the 59 end of some C. elegans were counted on a gridded background, and a percentage of the
number of progeny produced on the no drug control plate wastranscripts (Krause and Hirsh, 1987). Clones used for the chimeric
sequence were sequenced on both strands. The chimeric sequence calculated for each concentration. The number of L1 larva plated
for the assay was chosen so that at least 300 progeny were producedwas used to search the database of C. elegans genomic sequence,
and intron/exon boundaries were determined. The predicted peptide on the no drug control plate. For strains with wild-type fertility and
growth rate, 3 L1s were placed on each plate in the series; for strainssequence was used to search GenBank databases using BLAST
with decreased fertility or growth rate, correspondingly more L1s2.0 with default search parameters (Altschul et al., 1997). Related
were placed on each plate.sequences were compared to each other using the Genetics Com-
Plates used in the assay were prepared fresh for each set ofputer Group programs Bestfit and Pileup with default parameters.
assays. Aldicarb was added after autoclaving, when media had
cooled to 608C. Additions were made from a 105 mM stock of aldi-Molecular Analysis of Mutations
carb prepared fresh in 70% ethanol. The volume of drug 1 70%In cases where genomic regions were amplified from egl-8 mutants,
ethanol carrier was kept constant for each concentration. Twenty-populations of mutant animals were processed for PCR using the
four hours after the plates had been poured, 15 ml of OP-50 bacterialmethod of Williams et al. (1992).
culture was spread on each plate, leaving a clear border around theIdentification of the transposon insertion in md1933 is described
edge of the plate to minimize wandering onto the sides of the plate.above. PCR amplification of the relevant genomic region was used
Plates were incubated for 2 more days at room temperature, placedto confirm that the transposon was present in md1933 mutant strains
at 48C for 1 day, and then immediately used for the assay. To allow
but absent in N2, TR638 (from which md1933 was derived), and the
comparison between different sets of assays, plates were always
revertant strain.
prepared as described above, duplicate assays were performed,
The md153 deletion was identified by probing a Southern blot
and an N2 control was included with each set of strains. Over a series
of genomic DNA from md153 and control strains. The appropriate
of eight independent assays, N2 values (expressed as percentage
genomic region of md153 was amplified and sequenced along with
of the no drug control) ranged from 91% to 104% for 25 mM, 73%
the corresponding region from the parental strain RM25.
to 86% for 50 mM, 16% to 46% for 100 mM, and 0% to 6% for
Genomic DNA containing all egl-8 exons and intron/exon bound- 200 mM.
aries was amplified using PCR in md2243, n488, and md1971. The To test the aldicarb sensitivity of phorbol ester-treated wild-type
insertion in md2243 and the deletion in n488 were localized using worms, phorbol myristate acetate (Research Products; 5 mg/ml
PCR, and the PCR products spanning the lesions were sequenced. stock dissolved in 100% ethanol) was added to the 608C cooled
All exons and intron/exon boundaries were sequenced for the media to a final concentration of 300 nM before addition of aldicarb.
md1971 mutant. The assay then proceeded as described above except that six in-
stead of three wild-type L1s were plated, since the phorbol myristate
EGL-8 Antibodies and Immunostaining acetate reduced the growth rate of wild-type by about half.
Pfu polymerase (Stratagene) was used to amplify codons 1041±1382
from an egl-8 cDNA clone. BamHI and XhoI sites were incorporated Locomotion Assays
into the primers to facilitate directional in-frame cloning into the Locomotion rate was quantified by counting body bends of young
bacterial expression vector pRSETb (Invitrogen). The construct was adult animals on reproducibly thin lawns of OP-50 bacteria. Locomo-
tion assay plates were produced by spreading standard culturetransformed into the bacterial expression host BL21(DE3) pLysS,
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plates with 100 ml of OP-50 culture (grown 16 hr at 308C from a Fujita, Y., Sasaki, T., Fukui, K., Kotani, H., Kimura, T., Hata, Y.,
Sudhof, T.C., Scheller, R.H., and Takai, Y. (1996). Phosphorylationsingle colony). The bacterial lawn was grown 16 hr at 378C and then
of Munc-18/n-Sec1/rbSec1 by protein kinase C: its implication inplates were stored at 48C until needed. The assay was set up by
regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin.placing single late L3 or early L4 stage larva on each of 10 locomotion
J. Biol. Chem. 271(13), 7265±7268.assay plates. Plates were then placed at 208C for 24 hr, during which
time the larva matured to young adults (thus allowing egg-laying Hajdu-Cronin, Y.M., Chen, W.J., Patikoglou, G., Koelle, M.R., and
defective mutants to be assayed before they became engorged with Sternberg, P.W. (1999). Antagonism between Goa and Gqa in C.
eggs). To count body bends, a plate was equilibrated to 23±248C, elegans: the RGS protein EAT-16 is necessary for Goa signaling and
placed on the scope, and, after a 30 second period, body bends regulates Gqa activity. Genes Dev., 13, 1780±1793.
were counted for 3 min. A body bend was counted each time the Hunt, T.W., Fields, T.A., Casey, P.J., and Peralta, E.G. (1996). RGS10
tip of the tail passed through maximum or minimum amplitude. After is a selective activator of Gai GTPase activity. Nature 383, 175±177.
all 10 plates had been counted, the process was repeated two more
Iwasaki, K., Staunton, J.E., Saifee, O., Nonet, M.L., and Thomas,times on the same set of animals. Mean body bends/minute were
J.H. (1997). aex-3 encodes a novel regulator of presynaptic activity
calculated for each animal, and these means were used to calculate
in C. elegans. Neuron 18, 613±622.
the mean and standard error of the entire set of 10. For strains with
Koelle, M.R., and Horvitz, H.R. (1996). EGL-10 regulates G proteinstrongly reduced locomotion rate, the number of animals in a set
signaling in the C. elegans nervous system and shares a conservedwas reduced to five due to low variability.
domain with many mammalian proteins. Cell 84, 112±125.
Krause, M., and Hirsh, D. (1987). A trans-spliced leader sequenceAcknowledgments
on actin mRNA in C. elegans. Cell 49, 753±761.
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